These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37491777)

  • 1. In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH-PIATA, a new indole-3-acetamide synthetic cannabinoid.
    Norman C; Deventer MH; Dremann O; Reid R; Van Uytfanghe K; Guillou C; Vinckier IMJ; Nic Daéid N; Krotulski A; Stove CP
    Drug Test Anal; 2024 Apr; 16(4):380-391. PubMed ID: 37491777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the metabolism of CH-PIATA-A novel synthetic cannabinoid featuring an acetamide linker.
    Zschiesche A; Scheu M; Thieme D; Keiler AM; Pulver B; Huppertz LM; Auwärter V
    J Anal Toxicol; 2024 Jun; 48(5):359-371. PubMed ID: 38441323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new cannabinoid receptor 1 selective agonist evading the 2021 "China ban": ADB-FUBIATA.
    Deventer MH; Van Uytfanghe K; Vinckier IMJ; Reniero F; Guillou C; Stove CP
    Drug Test Anal; 2022 Sep; 14(9):1639-1644. PubMed ID: 35570246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs.
    Deventer MH; Persson M; Norman C; Liu H; Connolly MJ; Daéid NN; McKenzie C; Gréen H; Stove CP
    Drug Test Anal; 2024 Jun; 16(6):616-628. PubMed ID: 37903509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists.
    Deventer MH; Van Uytfanghe K; Vinckier IMJ; Reniero F; Guillou C; Stove CP
    Drug Test Anal; 2022 Sep; 14(9):1565-1575. PubMed ID: 35560866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons.
    Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C
    Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of the pyrazole-carrying synthetic cannabinoid receptor agonist 5F-3,5-AB-PFUPPYCA and its structural analogs.
    Deventer MH; Norman C; Reid R; McKenzie C; Nic Daéid N; Stove CP
    Forensic Sci Int; 2023 Feb; 343():111565. PubMed ID: 36640535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists.
    Norman C; Webling K; Kyslychenko O; Reid R; Krotulski AJ; Farrell R; Deventer MH; Liu H; Connolly MJ; Guillou C; Vinckier IMJ; Logan BK; NicDaéid N; McKenzie C; Stove CP; Gréen H
    Drug Test Anal; 2024 Sep; 16(9):915-935. PubMed ID: 38037247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
    Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
    Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolic profiling of new synthetic cannabinoids, ADB-FUBIATA, AFUBIATA, CH-FUBIATA, and CH-PIATA.
    Watanabe S; Yamane H; Iwai T; Matsushita R; Seto Y
    Arch Toxicol; 2023 Dec; 97(12):3085-3094. PubMed ID: 37755504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
    Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
    Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waxy- or Putty-Like Materials as a Novel Drug Preparation for Synthetic Cannabinoid Receptor Agonists: Detection in Prisons and In Vitro Cannabinoid Receptor Activity.
    Timmerman A; Deventer MH; Andrews R; Reid R; Marland V; Edwards D; Pudney CR; Nic Daéid N; Stove CP; Norman C
    Drug Test Anal; 2024 Oct; ():. PubMed ID: 39410765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and
    Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
    ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
    Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP
    Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
    Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
    Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity-based detection of synthetic cannabinoid receptor agonists in plant materials.
    Timmerman A; Balcaen M; Coopman V; Degreef M; Pottie E; Stove CP
    Harm Reduct J; 2024 Jul; 21(1):127. PubMed ID: 38951904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining Steric Requirements at CB
    Markham J; Sparkes E; Boyd R; Chen S; Manning JJ; Finlay D; Lai F; McGregor E; Maloney CJ; Gerona RR; Connor M; McGregor IS; Hibbs DE; Glass M; Kevin RC; Banister SD
    ACS Chem Neurosci; 2022 Apr; 13(8):1281-1295. PubMed ID: 35404067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations.
    Norman C; Halter S; Haschimi B; Acreman D; Smith J; Krotulski AJ; Mohr ALA; Logan BK; NicDaéid N; Auwärter V; McKenzie C
    Drug Test Anal; 2021 Apr; 13(4):841-852. PubMed ID: 33463894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?
    Ametovski A; Cairns EA; Grafinger KE; Cannaert A; Deventer MH; Chen S; Wu X; Shepperson CE; Lai F; Ellison R; Gerona R; Blakey K; Kevin R; McGregor IS; Hibbs DE; Glass M; Stove C; Auwärter V; Banister SD
    ACS Chem Neurosci; 2021 Nov; 12(21):4020-4036. PubMed ID: 34676751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons.
    Norman C; McKirdy B; Walker G; Dugard P; NicDaéid N; McKenzie C
    Drug Test Anal; 2021 Mar; 13(3):644-663. PubMed ID: 33058556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.